Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection

Blood

Volumn 90, Issue 3, 1997, Pages 1133-1140

  Lefrère, Jean Jacques ^a   Morand Joubert, Laurence ^b   Mariotti, Martine ^b   Bludau, Hubertus ^b   Burghoffer, Béatrice ^b   Petit, Jean Claude ^b   Roudot Thoraval, Françoise ^b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; BETA 2 MICROGLOBULIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEOPTERIN; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL;

EID: 1842414800     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.1133     Document Type: Article

References (23)

1. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355, 1993
2. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123, 1995
3. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117, 1995
4. Hardy AM, the Long-term Survivor Collaborative Study Group: Characterization of long-term survivors of acquired immunodeficiency syndrome. J Acquir Immun Defic Syndr 4:386, 1991
5. Learmont J, Tindall B, Evans L, Cunningham A, Cunningham P, Wells J, Penny R, Kaldor J, Cooper DA: Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 340:863, 1992
6. Cao Y, Qin L, Zhang L, Safrit J, Ho DD: Virologie and immunologie characterization of long-term survivors of human immunodeficiency virus type I infection. N Engl J Med 332:201, 1995
7. + T-cell levels. AIDS 7:1159, 1993
8. Keet IPM, Krol A, Klein MR, Veugelers P, De Witt J, Roos M, Koot M, Goudsmit J, Miedema F, Coutinho RA; Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. J Infect Dis 169:1236, 1994
9. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD: Long-term HIV-1 infection without immunologie progression. AIDS 8:1123, 1994
10. Schlechter MT, Craib KJP, Le TN, et al: Susceptibility to AIDS progression appears early in HIV infection. AIDS 4:185, 1990
11. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type-I-infected individuals. J Virol 67:1772, 1993
12. Mellors JW, Kingsley LA, Rinaldo CR, Todd JA, Hoo BS, Kokka RP, Gupta P: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122:573, 1995
13. Goudsmit J, Lange JMA, Paul D, Dawson GJ: Antigenemia and antibody titers to core and envelope antigens in AIDS and AIDS-related complex, and subclinical human immunodeficiency virus infection. J Infect Dis 155:558, 1987
14. Hogervorst E, Jurrians S, DeWoIf F, Hofman B, Melmed R, Nishanian P, Giorgi JV: Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: Low viral RNA copy numbers in serum and maintenance of high HIV-p24-specific but not V3-specific antibody levels. J Infect Dis 171:811, 1995
15. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishaninan P: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 322:166, 1990
16. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schrager LK, Margolick JB. Buchbinder S, Giorgi JV, Fauci AS: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332:209, 1995
17. Kievits T, VanGemen B, VanStrijp D, Schukking R, Adriaanse H, Malek L, Sooknanan R, Lens P: NASBA™ isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods 35:273, 1991
18. VanGemen B, VanBeuningen R, Nabbe A, VanStrijp D, Jurrians S, Kievits: A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J Virol Methods 49:157, 1994
19. Bollinger RC, Kline RL, Francis HL, Moss MW, Bartlett JG, Quinn TC. Acid dissociation increases the sensitivity of p24 antigen detection for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons. J Infect Dis 165:913, 1992
20. Morand-Joubert L, Costagliola D, Bludau H, Petit JC, Lefrère JJ: Predicting progression of HIV disease: Usefulness of acid dissociated p24 antigen. J Acquir Immune Defic Syndr 7:676, 1994
21. Morand-Joubert L, Mariotti M, Reed D, Petit JC, Lefrère JJ: Correlation between viral DNA load and serum anti-p19 antibody concentration in symptomless human T-lymphotropic virus type I (HTLV-I)-infected individuals. Int J Cancer 60:156, 1995
22. Ho DD, Mougdil T, Alam M: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 321:1621, 1989
23. Barker E, Mackewicz CE, Levy JA: Effects of THI and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: Implications for long-term survival. Proc Natl Acad Sci USA 92:11135, 1995